Inventor · disambiguated record
Karim Dabbagh
Also filed as: DABBAGH KARIM
11 granted patents·6 pending applications·11 citations·filing 2018–2023
84Inventor score
Top patents by PatentIndex Score
17 records- 0188US11174293B2Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2018·Granted Nov 16, 2021·3 cites·16 claims
- 0288US10251933B2Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2018·Granted Apr 9, 2019·4 cites·18 claims
- 0381US12168677B2Proteins for the treatment of epithelial barrier function disordersGENEVIVE INC·Filed 2023·Granted Dec 17, 2024·0 cites·18 claims
- 0477US11273198B2Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2018·Granted Mar 15, 2022·2 cites·13 claims
- 0577US11207376B2Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2018·Granted Dec 28, 2021·1 cites·24 claims
- 0674US2024066095A1Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2023·Application pending·0 cites
- 0773US12371456B2Proteins for the treatment of epithelial barrier function disordersGENEVIVE INC·Filed 2022·Granted Jul 29, 2025·0 cites·14 claims
- 0872US12186364B2Proteins for the treatment of epithelial barrier function disordersGENEVIVE INC·Filed 2022·Granted Jan 7, 2025·0 cites·3 claims
- 0970US11666627B2Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2019·Granted Jun 6, 2023·1 cites·16 claims
- 1068US2022106365A1Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2021·Application pending·0 cites
- 1167US2024115625A1Roseburia hominis, eubacterium eligens, and combinations thereof as biotherapeuticsGENEVIVE INC·Filed 2023·Application pending·0 cites
- 1262US11344584B2Gemella sanguinis as a biotherapeuticSECOND GENOME INC·Filed 2018·Granted May 31, 2022·0 cites·19 claims
- 1356US2022185849A1Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2018·Application pending·0 cites
- 1453US2024317816A1Peptides for immunotherapyGENEVIVE INC·Filed 2022·Application pending·0 cites
- 1553US2020376044A1Roseburia hominis, eubacterium eligens, and combinations thereof as biotherapeuticsGUJRAL TARUNMEET·Filed 2018·Application pending·0 cites
- 1650US12168676B2Microbially derived peptides and proteins for immunotherapyGENEVIVE INC·Filed 2020·Granted Dec 17, 2024·0 cites·10 claims
- 1744US11389487B2Streptococcus australis as a biotherapeuticSECOND GENOME INC·Filed 2018·Granted Jul 19, 2022·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Karim Dabbagh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →